Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Investigating the Promoter of FAT10 Gene in HCC Patients.

Liu S, Jin Y, Zhang D, Wang J, Wang G, Lee CGL.

Genes (Basel). 2018 Jun 26;9(7). pii: E319. doi: 10.3390/genes9070319.

2.

Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers.

Lee CG, Ren J, Cheong IS, Ban KH, Ooi LL, Yong Tan S, Kan A, Nuchprayoon I, Jin R, Lee KH, Choti M, Lee LA.

Oncogene. 2003 May 1;22(17):2592-603.

PMID:
12730673
3.

Genetic variation in the Fat10 gene is associated with risk of hepatocellular carcinoma in a Chinese population.

Yuan R, Jiang C, Hong K, Yu X, Wu L, Liu T, Liu X, Tang X, Cai H, Shao J.

Asian Pac J Cancer Prev. 2011;12(8):2117-22.

4.

p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers.

Zhang DW, Jeang KT, Lee CG.

Oncogene. 2006 Apr 13;25(16):2318-27.

PMID:
16501612
5.

As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3β pathway.

Liu L, Dong Z, Liang J, Cao C, Sun J, Ding Y, Wu D.

Oncogene. 2014 Feb 13;33(7):909-20. doi: 10.1038/onc.2013.236. Epub 2013 Jul 1.

PMID:
23812429
6.

Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon.

Lukasiak S, Schiller C, Oehlschlaeger P, Schmidtke G, Krause P, Legler DF, Autschbach F, Schirmacher P, Breuhahn K, Groettrup M.

Oncogene. 2008 Oct 9;27(46):6068-74. doi: 10.1038/onc.2008.201. Epub 2008 Jun 23.

PMID:
18574467
7.
8.

Quantitative analysis of APC promoter methylation in hepatocellular carcinoma and its prognostic implications.

Xu B, Nie Y, Liu X, Feng S, Yang Z, Wang Z, Zheng Q, Luo X.

Oncol Lett. 2014 May;7(5):1683-1688. Epub 2014 Mar 7.

9.

Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.

Yuan R, Wang K, Hu J, Yan C, Li M, Yu X, Liu X, Lei J, Guo W, Wu L, Hong K, Shao J.

Cancer Res. 2014 Sep 15;74(18):5287-300. doi: 10.1158/0008-5472.CAN-14-0284. Epub 2014 Jul 23.

10.

Genomic aberrations in the HTPAP promoter affect tumor metastasis and clinical prognosis of hepatocellular carcinoma.

Wu JC, Jia HL, Li ZR, Zhou KL, Qin LX, Dong QZ, Ren N.

PLoS One. 2014 Mar 6;9(3):e90528. doi: 10.1371/journal.pone.0090528. eCollection 2014.

11.

Recombinant adenovirus encoding FAT10 small interfering RNA inhibits HCC growth in vitro and in vivo.

Chen J, Yang L, Chen H, Yuan T, Liu M, Chen P.

Exp Mol Pathol. 2014 Apr;96(2):207-11. doi: 10.1016/j.yexmp.2014.01.001. Epub 2014 Jan 14.

PMID:
24440736
12.

FAT10 plays a role in the regulation of chromosomal stability.

Ren J, Kan A, Leong SH, Ooi LL, Jeang KT, Chong SS, Kon OL, Lee CG.

J Biol Chem. 2006 Apr 21;281(16):11413-21. Epub 2006 Feb 22.

13.

Decreased Expression of BNC1 and BNC2 Is Associated with Genetic or Epigenetic Regulation in Hepatocellular Carcinoma.

Wu Y, Zhang X, Liu Y, Lu F, Chen X.

Int J Mol Sci. 2016 Jan 25;17(2). pii: E153. doi: 10.3390/ijms17020153.

14.

Aberrant TIG1 methylation associated with its decreased expression and clinicopathological significance in hepatocellular carcinoma.

Chen XH, Wu WG, Ding J.

Tumour Biol. 2014 Feb;35(2):967-71. doi: 10.1007/s13277-013-1129-9. Epub 2013 Sep 5.

PMID:
24006221
15.

Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.

Kong LM, Liao CG, Chen L, Yang HS, Zhang SH, Zhang Z, Bian HJ, Xing JL, Chen ZN.

J Cell Mol Med. 2011 Jun;15(6):1415-28. doi: 10.1111/j.1582-4934.2010.01124.x. Epub 2010 Jul 12.

16.

Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma.

Formeister EJ, Tsuchiya M, Fujii H, Shpyleva S, Pogribny IP, Rusyn I.

Mutat Res. 2010 Oct 13;692(1-2):26-33. doi: 10.1016/j.mrfmmm.2010.07.013. Epub 2010 Aug 22.

17.

Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.

Li Z, Zhang H, Yang J, Hao T, Li S.

Cell Biol Int. 2012 May 1;36(5):427-32. doi: 10.1042/CBI20100851.

PMID:
21864295
18.

FAT10 mediates the effect of TNF-α in inducing chromosomal instability.

Ren J, Wang Y, Gao Y, Mehta SB, Lee CG.

J Cell Sci. 2011 Nov 1;124(Pt 21):3665-75. doi: 10.1242/jcs.087403. Epub 2011 Oct 24.

19.

Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.

Zhang W, Zhou L, Ding SM, Xie HY, Xu X, Wu J, Chen QX, Zhang F, Wei BJ, Eldin AT, Zheng SS.

Oncol Rep. 2011 Apr;25(4):1053-62. doi: 10.3892/or.2011.1159. Epub 2011 Jan 24.

PMID:
21271221
20.

Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma.

Qiu GH, Xie H, Wheelhouse N, Harrison D, Chen GG, Salto-Tellez M, Lai P, Ross JA, Hooi SC.

J Hepatol. 2007 Apr;46(4):655-63. Epub 2006 Dec 12.

PMID:
17258345

Supplemental Content

Support Center